J.P. Morgan Securities LLC Allergan plc 38.5(b) (3293L)
April 29 2020 - 6:30AM
UK Regulatory
TIDM0Y7T
RNS Number : 3293L
J.P. Morgan Securities LLC
29 April 2020
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT
RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED
INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal J.P Morgan Securities LLC
trader
Company dealt in Allergan plc
=========================
Class of relevant security Ordinary Share
to which the dealings
being disclosed relate
(Note 1)
=========================
Date of dealing 28 April 2020
=========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 2)
Long Short
Number (%) Number (%)
========= ====== =========== ======
3,983,328
(1) Relevant securities 5,339,453 1.62 1.21
================= ===================
(2) Derivatives (other 4,583,355
than options) 3,817,157 1.16 1.39
================= ===================
(3) Options and agreements
to purchase/sell 305,000 0.09 0 0.00
================= ===================
8,566,683
Total 9,461,610 2.87 2.60
================= ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 2)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 4)
Purchases 100 186.8000 USD
200 186.8550 USD
100 186.8600 USD
62 186.8900 USD
100 186.9100 USD
100 187.0300 USD
20 187.0700 USD
518 187.1108 USD
300 187.1367 USD
1,418 187.3500 USD
528 187.4223 USD
300 187.4700 USD
3 187.4933 USD
657 187.5076 USD
2 187.5750 USD
400 187.5875 USD
100 187.6200 USD
100 187.6302 USD
100 187.6400 USD
2 187.6450 USD
1 187.6800 USD
50 187.6836 USD
200 187.7050 USD
1 187.7200 USD
100 187.7600 USD
500 187.7820 USD
9 187.8200 USD
500 188.0740 USD
529 188.0968 USD
115 189.0006 USD
Sales 40 187.0700 USD
400 187.2025 USD
77 187.2077 USD
3,321 187.3500 USD
29 187.7300 USD
9 187.8200 USD
==================================== ===================
(b) Derivatives transactions (other than options transactions)
Product Nature of transaction Number of relevant Price per
name, (Note 5) securities unit
e.g. CFD (Note 6) (Note 4)
Equity Swaps Long 20 187.0700
USD
====================== =================== ==========
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 4)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
4)
(d) Other dealings (including transactions in respect of new
securities) (Note 3)
Nature of transaction Details Price per unit
(Note 7) (if applicable)
(Note 4)
Ap29
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other
person relating to the voting rights of any relevant securities
under any option referred to on this form or relating to the
voting rights or future acquisition
or disposal of any relevant securities to which any derivative
referred to on this form is referenced.
If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES
Date of disclosure 29 April 2020
Contact name Alwyn Basch
=============================
Telephone number 020 7742 7407
=============================
Name of offeree/offeror Allergan plc
with which connected
=============================
Nature of connection (Note Financial Advisor to Allergan
9) plc
=============================
Ap31
SUPPLEMENTAL FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)
Product Written Number of Exercise Type, e.g. Expiry
name, or purchased relevant price American, date
e.g. call securities (Note European
option to which 2) etc.
the option
or derivative
relates
Put Option Written 300,000 150.00 American 19JUN20
Put Option Written 5,000 140.00 American 19JUN20
============== =============== ========= =========== ========
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full details should be given. Full
details of any existing agreements to purchase or to sell must also
be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rules 8 and
38.5 of the Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEZZGZDGLVGGZM
(END) Dow Jones Newswires
April 29, 2020 06:30 ET (10:30 GMT)
Allergan (LSE:0Y7T)
Historical Stock Chart
From Jun 2024 to Jul 2024
Allergan (LSE:0Y7T)
Historical Stock Chart
From Jul 2023 to Jul 2024
